Logo image of CVNA

CARVANA CO (CVNA) Stock Fundamental Analysis

NYSE:CVNA - New York Stock Exchange, Inc. - US1468691027 - Common Stock - Currency: USD

219.45  -13.65 (-5.86%)

After market: 220 +0.55 (+0.25%)

Fundamental Rating

5

Overall CVNA gets a fundamental rating of 5 out of 10. We evaluated CVNA against 121 industry peers in the Specialty Retail industry. Both the profitability and the financial health of CVNA get a neutral evaluation. Nothing too spectacular is happening here. CVNA is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year CVNA was profitable.
In the past year CVNA had a positive cash flow from operations.
In multiple years CVNA reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: CVNA reported negative operating cash flow in multiple years.
CVNA Yearly Net Income VS EBIT VS OCF VS FCFCVNA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1B -2B -3B

1.2 Ratios

CVNA has a Return On Assets (2.48%) which is comparable to the rest of the industry.
CVNA's Return On Equity of 16.67% is fine compared to the rest of the industry. CVNA outperforms 74.58% of its industry peers.
CVNA has a Return On Invested Capital of 11.76%. This is in the better half of the industry: CVNA outperforms 79.66% of its industry peers.
Industry RankSector Rank
ROA 2.48%
ROE 16.67%
ROIC 11.76%
ROA(3y)-3.14%
ROA(5y)-3.39%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CVNA Yearly ROA, ROE, ROICCVNA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200 300

1.3 Margins

The Profit Margin of CVNA (1.54%) is comparable to the rest of the industry.
CVNA's Operating Margin of 7.24% is fine compared to the rest of the industry. CVNA outperforms 77.12% of its industry peers.
CVNA has a Gross Margin of 21.03%. This is amonst the worse of the industry: CVNA underperforms 80.51% of its industry peers.
CVNA's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 7.24%
PM (TTM) 1.54%
GM 21.03%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.8%
GM growth 5Y10.37%
CVNA Yearly Profit, Operating, Gross MarginsCVNA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

6

2. Health

2.1 Basic Checks

CVNA has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for CVNA has been increased compared to 1 year ago.
The number of shares outstanding for CVNA has been increased compared to 5 years ago.
The debt/assets ratio for CVNA has been reduced compared to a year ago.
CVNA Yearly Shares OutstandingCVNA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CVNA Yearly Total Debt VS Total AssetsCVNA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

An Altman-Z score of 6.28 indicates that CVNA is not in any danger for bankruptcy at the moment.
CVNA has a Altman-Z score of 6.28. This is amongst the best in the industry. CVNA outperforms 94.92% of its industry peers.
CVNA has a debt to FCF ratio of 6.81. This is a slightly negative value and a sign of low solvency as CVNA would need 6.81 years to pay back of all of its debts.
CVNA has a Debt to FCF ratio of 6.81. This is comparable to the rest of the industry: CVNA outperforms 57.63% of its industry peers.
A Debt/Equity ratio of 4.22 is on the high side and indicates that CVNA has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 4.22, CVNA is doing worse than 78.81% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 4.22
Debt/FCF 6.81
Altman-Z 6.28
ROIC/WACC1.23
WACC9.59%
CVNA Yearly LT Debt VS Equity VS FCFCVNA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B 6B

2.3 Liquidity

A Current Ratio of 3.64 indicates that CVNA has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 3.64, CVNA belongs to the top of the industry, outperforming 94.07% of the companies in the same industry.
CVNA has a Quick Ratio of 2.44. This indicates that CVNA is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of CVNA (2.44) is better than 94.92% of its industry peers.
Industry RankSector Rank
Current Ratio 3.64
Quick Ratio 2.44
CVNA Yearly Current Assets VS Current LiabilitesCVNA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

8

3. Growth

3.1 Past

CVNA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 144.60%, which is quite impressive.
CVNA shows a strong growth in Revenue. In the last year, the Revenue has grown by 26.94%.
Measured over the past years, CVNA shows a very strong growth in Revenue. The Revenue has been growing by 28.25% on average per year.
EPS 1Y (TTM)144.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%156%
Revenue 1Y (TTM)26.94%
Revenue growth 3Y2.19%
Revenue growth 5Y28.25%
Sales Q2Q%46.33%

3.2 Future

The Earnings Per Share is expected to grow by 42.80% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 22.39% on average over the next years. This is a very strong growth
EPS Next Y48.47%
EPS Next 2Y64.16%
EPS Next 3Y52.57%
EPS Next 5Y42.8%
Revenue Next Year18.01%
Revenue Next 2Y18.16%
Revenue Next 3Y17.13%
Revenue Next 5Y22.39%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
CVNA Yearly Revenue VS EstimatesCVNA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 20B 40B 60B
CVNA Yearly EPS VS EstimatesCVNA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 5 -5 10 -10

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 139.78, which means the current valuation is very expensive for CVNA.
Compared to the rest of the industry, the Price/Earnings ratio of CVNA is on the same level as its industry peers.
When comparing the Price/Earnings ratio of CVNA to the average of the S&P500 Index (29.75), we can say CVNA is valued expensively.
Based on the Price/Forward Earnings ratio of 94.14, the valuation of CVNA can be described as expensive.
CVNA's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. CVNA is more expensive than 64.41% of the companies in the same industry.
CVNA is valuated expensively when we compare the Price/Forward Earnings ratio to 22.44, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 139.78
Fwd PE 94.14
CVNA Price Earnings VS Forward Price EarningsCVNA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CVNA is valued a bit more expensive than the industry average as 64.41% of the companies are valued more cheaply.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CVNA is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 55.1
EV/EBITDA 40.35
CVNA Per share dataCVNA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CVNA does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as CVNA's earnings are expected to grow with 52.57% in the coming years.
PEG (NY)2.88
PEG (5Y)N/A
EPS Next 2Y64.16%
EPS Next 3Y52.57%

0

5. Dividend

5.1 Amount

No dividends for CVNA!.
Industry RankSector Rank
Dividend Yield N/A

CARVANA CO

NYSE:CVNA (3/3/2025, 8:24:05 PM)

After market: 220 +0.55 (+0.25%)

219.45

-13.65 (-5.86%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)02-19 2025-02-19/amc
Earnings (Next)04-29 2025-04-29/amc
Inst Owners98.22%
Inst Owner Change5.51%
Ins Owners1.79%
Ins Owner Change-3.95%
Market Cap45.56B
Analysts74.67
Price Target250.93 (14.34%)
Short Float %8.65%
Short Ratio3.47
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.03
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)124.18%
Min EPS beat(2)88.58%
Max EPS beat(2)159.78%
EPS beat(4)4
Avg EPS beat(4)171.21%
Min EPS beat(4)88.58%
Max EPS beat(4)305.93%
EPS beat(8)7
Avg EPS beat(8)99.59%
EPS beat(12)8
Avg EPS beat(12)63.41%
EPS beat(16)10
Avg EPS beat(16)56.52%
Revenue beat(2)2
Avg Revenue beat(2)4.37%
Min Revenue beat(2)3.81%
Max Revenue beat(2)4.94%
Revenue beat(4)4
Avg Revenue beat(4)6.01%
Min Revenue beat(4)3.05%
Max Revenue beat(4)12.25%
Revenue beat(8)5
Avg Revenue beat(8)3.26%
Revenue beat(12)6
Avg Revenue beat(12)0.18%
Revenue beat(16)10
Avg Revenue beat(16)3.55%
PT rev (1m)0.6%
PT rev (3m)2.85%
EPS NQ rev (1m)3.66%
EPS NQ rev (3m)20.97%
EPS NY rev (1m)-0.23%
EPS NY rev (3m)-2.95%
Revenue NQ rev (1m)5.68%
Revenue NQ rev (3m)7.08%
Revenue NY rev (1m)0.71%
Revenue NY rev (3m)1.51%
Valuation
Industry RankSector Rank
PE 139.78
Fwd PE 94.14
P/S 3.33
P/FCF 55.1
P/OCF 49.63
P/B 36.16
P/tB 37.17
EV/EBITDA 40.35
EPS(TTM)1.57
EY0.72%
EPS(NY)2.33
Fwd EY1.06%
FCF(TTM)3.98
FCFY1.82%
OCF(TTM)4.42
OCFY2.01%
SpS65.85
BVpS6.07
TBVpS5.9
PEG (NY)2.88
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.48%
ROE 16.67%
ROCE 13.85%
ROIC 11.76%
ROICexc 15.44%
ROICexgc 15.53%
OM 7.24%
PM (TTM) 1.54%
GM 21.03%
FCFM 6.05%
ROA(3y)-3.14%
ROA(5y)-3.39%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.8%
GM growth 5Y10.37%
F-Score7
Asset Turnover1.61
Health
Industry RankSector Rank
Debt/Equity 4.22
Debt/FCF 6.81
Debt/EBITDA 4.11
Cap/Depr 29.84%
Cap/Sales 0.67%
Interest Coverage 8.61
Cash Conversion 70.89%
Profit Quality 393.81%
Current Ratio 3.64
Quick Ratio 2.44
Altman-Z 6.28
F-Score7
WACC9.59%
ROIC/WACC1.23
Cap/Depr(3y)83.57%
Cap/Depr(5y)253.76%
Cap/Sales(3y)1.75%
Cap/Sales(5y)3.2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)144.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%156%
EPS Next Y48.47%
EPS Next 2Y64.16%
EPS Next 3Y52.57%
EPS Next 5Y42.8%
Revenue 1Y (TTM)26.94%
Revenue growth 3Y2.19%
Revenue growth 5Y28.25%
Sales Q2Q%46.33%
Revenue Next Year18.01%
Revenue Next 2Y18.16%
Revenue Next 3Y17.13%
Revenue Next 5Y22.39%
EBIT growth 1Y1494.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year79.05%
EBIT Next 3Y41.83%
EBIT Next 5Y31.43%
FCF growth 1Y15.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y14.32%
OCF growth 3YN/A
OCF growth 5YN/A